Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | BMY | AMGN | GILD | ILMN |
| Company | Ligand Pharm | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 69.46 | 49.00 | 270.63 | 66.58 | 123.09 |
| High | 71.00 | 49.05 | 274.86 | 67.18 | 124.74 |
| Low | 69.17 | 48.55 | 269.64 | 66.36 | 120.82 |
| Last | 71.00 | 48.86 | 273.01 | 67.08 | 122.87 |
| Change | +1.11 | -0.13 | -0.53 | +0.05 | -1.59 |
| % Change | +1.59% | -0.27% | -0.19% | +0.07% | -1.28% |
| Volume | 152,900 | 16,057,100 | 2,467,100 | 8,467,000 | 1,254,600 |
| 20-Day Average Volume | 163,760 | 11,259,110 | 2,172,705 | 6,490,535 | 1,515,500 |
| Previous Close | 69.89 | 48.99 | 273.54 | 67.03 | 124.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 75.97 | 50.37 | 271.55 | 69.07 | 126.51 |
| 20-Day Raw Stochastic | 23.41% | 18.15% | 44.22% | 14.81% | 29.33% |
| 20-Day Relative Strength | 43.70% | 41.15% | 48.18% | 33.12% | 43.68% |
| Weighted Alpha | -2.75 | -26.02 | +11.15 | -20.78 | -37.29 |
| Today's Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 24% Buy | 88% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.98% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +3.87% since 04/17/24 |
| Low | 67.72 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 78.70 on 04/18/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | unch since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -10.47% since 03/22/24 |
| Low | 67.72 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 81.73 on 04/12/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -4.27% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -12.86% since 01/24/24 |
| Low | 67.72 on 04/22/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 94.57 on 02/27/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +36.83% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +5.83% since 10/24/23 |
| Low | 49.24 on 10/27/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 94.57 on 02/27/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,237,402 | 99,290,928 | 146,720,288 | 83,457,512 | 19,820,878 |
| Shares Outstanding, K | 17,705 | 2,026,759 | 536,376 | 1,245,077 | 159,255 |
| Annual Sales | 131,310,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | 52,150,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 28,100,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 18,190,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.01 | 0.39 | 0.58 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.05 on 02/27/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | 2.500 on 04/03/07 | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 15.03 | 6.55 | 14.58 | 9.96 | 138.22 |